ArticleMedicine2025
Remitting seronegative symmetrical synovitis with pitting edema syndrome with two different underlying malignancies: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleRemitting seronegative symmetric synovitis with pitting edema is a rare, benign disorder symmetrically affecting the peripheral joints. It begins with acute-onset pitting edema on the dorsum of the hands and feet, and primarily affects elderly men and has a favorable response to low-dose steroids. It may also be a paraneoplastic symptom of an underlying hidden cancer; hence, thorough clinical evaluation is required. PATIENT CONCERNS: A 58-year-old woman who presented with acute-onset polyarthritis and pitting edema affecting both hands and feet. Based on clinical and laboratory findings, remitting seronegative symmetric synovitis with pitting edema was diagnosed. A thorough clinical investigation led to a diagnosis of papillary thyroid carcinoma and adenocarcinoma of unknown origin. DIAGNOSES: Based on clinical and laboratory findings, remitting seronegative symmetric synovitis with pitting edema was diagnosed. A thorough clinical investigation led to a diagnosis of papillary thyroid carcinoma and adenocarcinoma of unknown origin.
interventionsThe patient initially received prednisolone; when she faced difficulty in maintaining remission at a dose of <12.5 mg, hydroxychloroquine was added. Subsequently, the corticosteroid dose was tapered successfully without further arthritis flares. She also received palliative chemotherapy for an unknown primary. OUTCOMES: Five rounds of chemotherapy successfully reduced the size of bilateral inguinal lymphadenopathy and garnered resolution of the small bilateral external iliac lymph nodes. Both corticosteroid and hydroxychloroquine discontinued. The patient remained stable and cancer-free at the 9-month follow-up. LESSONS: Physicians should be knowledgeable about the distinct signs and symptoms of remitting seronegative symmetric synovitis with pitting edema and investigate patients suspected of having the syndrome for hidden cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.